Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy
Abstract Background As a marker of differentiation, Killer cell lectin like receptor G1 (KLRG1) plays an inhibitory role in human NK cells and T cells. However, its clinical role remains inexplicit. This work intended to investigate the predictive ability of KLRG1 on the efficacy of immune-checkpoin...
Main Authors: | Xiaodong Yang, Yuexin Zheng, Zhihai Han, Xiliang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08510-3 |
Similar Items
-
Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers
by: Angela Tata, et al.
Published: (2021-01-01) -
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
by: Sijin Sun, et al.
Published: (2021-03-01) -
A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
by: Yujia Zheng, et al.
Published: (2021-03-01) -
The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
by: Jae Jun Kim, et al.
Published: (2015-10-01) -
Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
by: Xuanwen Bao, et al.
Published: (2020-05-01)